Phibro Animal Health Corporation (PAHC) vs Stoke Therapeutics, Inc. (STOK)
A side-by-side comparison of Phibro Animal Health Corporation and Stoke Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PAHC
Phibro Animal Health Corporation
$36.61HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
STOK
Stoke Therapeutics, Inc.
$24.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — PAHC vs STOK
growth of $100 · dividends reinvested · last 7yPAHC +49.4% (+5.9%/yr)STOK -1.0% (-0.1%/yr)PAHC compounded faster over this window
PAHC STOK
PAHC vs STOK: by the numbers
- •STOK is the larger company ($1.57B vs $1.48B market cap).
- •PAHC is profitable (6.57% net margin) while STOK runs a net loss (-753.60%).
- •PAHC pays a dividend (1.29% yield), while STOK has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | PAHC | STOK |
|---|---|---|
| P/E ratio | 15.00 | N/A |
| Forward P/E | 10.46 | N/A |
| PEG ratio | 1.18 | N/A |
| P/S ratio | 0.98 | 57.00 |
| P/B ratio | 3.85 | 4.55 |
| EV / EBITDA | 8.85 | N/A |
| FCF yield | 0.66% | N/A |
Profitability
| Metric | PAHC | STOK |
|---|---|---|
| Gross margin | 33.71% | 100.00% |
| Operating margin | 13.07% | -11.16% |
| Net margin | 6.57% | -753.60% |
| ROE | 25.87% | -60.17% |
| ROIC | 11.91% | -63.12% |
Dividends
| Metric | PAHC | STOK |
|---|---|---|
| Dividend yield | 1.29% | N/A |
| Payout ratio | 19.67% | N/A |
Growth (annualized)
| Metric | PAHC | STOK |
|---|---|---|
| Revenue CAGR (5Y) | 12.75% | N/A |
| EPS CAGR (5Y) | 12.92% | N/A |
| FCF CAGR (5Y) | -12.27% | N/A |
| Total return CAGR (5Y) | 14.40% | -0.24% |
Frequently asked
- Does PAHC or STOK pay a bigger dividend?
- PAHC pays a dividend (1.29% yield), while STOK has no payments in the available dividend history.
- Is PAHC or STOK more profitable?
- PAHC runs the higher net margin — PAHC at 6.57% versus STOK at -753.60%.
- How have PAHC and STOK total returns compared?
- Over the past 5 years, PAHC delivered 14.40% and STOK delivered -0.24% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Phibro Animal Health P/E ratioPhibro Animal Health dividend yieldPhibro Animal Health ROEStoke Therapeutics ROEPhibro Animal Health operating marginStoke Therapeutics operating marginPhibro Animal Health revenue growthStoke Therapeutics revenue growthPhibro Animal Health free cash flowStoke Therapeutics free cash flow
Phibro Animal Health & Stoke Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.